Skip to main content
SpringerLink
Log in

Inflammatory and Connective Tissue Disorders of the Aorta

  • Chapter
  • First Online:
Diseases of the Aorta

Abstract

This chapter discusses connective tissue diseases and inflammatory disorders that are known to affect the aorta and its major branches. While some of the diseases discussed in this chapter are quite rare, all have been associated with potentially life-threatening aortic complications making them an uncommon, but significant, clinical challenge. This chapter serves as a comprehensive review of the epidemiology, pathophysiology, clinical presentation, and available medical and surgical treatments for aortic disease in each of these unique patient populations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gonzalez-Gay MA, Martinez-Dubois C, Agudo M, Pompei O, Blanco R, Llorca J. Giant cell arteritis: epidemiology, diagnosis, and management. Curr Rheumatol Rep. 2010;12(6):436–42. Web

    Article  PubMed  Google Scholar 

  2. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum. 2010;33:1074–87.

    Article  Google Scholar 

  3. Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev. 2012; https://doi.org/10.1016/j.autrev.2012.01.003.

    Article  PubMed  Google Scholar 

  4. Solomon CG, Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia Rheumatica. N Engl J Med. 2014;371:50–7.

    Article  CAS  Google Scholar 

  5. Jenette JC, Weimer ET, Kidd J. Henry’s clinical diagnosis and management by laboratory methods: St Loius, Mo: Elsevier; 2017. p. 1016–31.

    Google Scholar 

  6. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM, Hunder GG, Therneau TM, Gabriel SE. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:633–9.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Docken WP, Rosenbaum JT. Clinical manifestations of giant cell (temporal) arteritis. In: UpToDate. 2016. https://www.uptodate.com/contents/clinical-manifestations-of-giant-cell-temporalarteritis?source=search_result&search=anterior+ischemic+optic+neuropathy&selectedTitle=5~33. Accessed 5 Dec 2016.

  8. Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234–45.

    Article  PubMed  Google Scholar 

  9. Hellmann DB. Giant cell arteritis, polymyalgia rheumatica, and Takayasu’s arteritis. Kelley’s textbook of rheumatology; Elsevier Inc Piladelphia PA: 2013. p. 1461–80.

    Google Scholar 

  10. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 2010;33:1122–8.

    Article  Google Scholar 

  11. Dasgupta B, Cimmino MA, Maradit-Kremers H, et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis. 2012;71:484–92.

    Article  PubMed  Google Scholar 

  12. Martínez-Valle F, Solans-Laqué R, Bosch-Gil J, Vilardell-Tarrés M. Aortic involvement in giant cell arteritis. Autoimmun Rev. 2010;9:521–4.

    Article  PubMed  Google Scholar 

  13. Marie I, Proux A, Duhaut P, Primard E, Lahaxe L, Girszyn N, Louvel J-P, Levesque HA. Long-term follow-up of aortic involvement in giant cell arteritis. Medicine. 2009;88:182–92.

    Article  PubMed  Google Scholar 

  14. Evans JM, O’Fallon WM, Hunter GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med. 1995;122:502.

    Article  CAS  PubMed  Google Scholar 

  15. Gonzalez-Gay MA, Garcia-Porrua C, Pego-Reigosa R, Llorca J, Hunder GG, Pineiro A. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain. Medicine. 2004;83:335–41.

    Article  PubMed  Google Scholar 

  16. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CGM, Merkel PA, Raspe H, Salvarani C, Scott DGI, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R. Europeal League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. Ann Rheum Dis. 6:310–7.

    Google Scholar 

  17. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary. J Am Coll Cardiol. 2010;55(14):1509–44. Web

    Article  Google Scholar 

  18. Smetana GW. Does this patient have temporal arteritis? JAMA. 2002;287:92.

    Article  PubMed  Google Scholar 

  19. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum. 1999;42:311–7.

    Article  CAS  PubMed  Google Scholar 

  20. Gonzalez-Gay M, Lopez-Diaz M, Barros S, Garcia-Porrua C, Sanchez-Andrade A, Paz-Carreira J, Martin J, Llorca J. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Am J Ophthalmol. 2006;141:1172–3.

    Article  Google Scholar 

  21. Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 1993;36:1286–94.

    Article  CAS  PubMed  Google Scholar 

  22. Hernandez-Rodriguez J. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation. 2003;107:2428–34.

    Article  CAS  PubMed  Google Scholar 

  23. Weyand CM, Fulbright JW, Hunder GG, Evans JM, Goronzy JJ. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. Arthritis Rheum. 2000;43:1041.

    Article  CAS  PubMed  Google Scholar 

  24. Rittner HL, Kaiser M, Brack A, Szweda LI, Goronzy JJ, Weyand CM. Tissue-destructive macrophages in giant cell arteritis. Circ Res. 1999;84:1050–8.

    Article  CAS  PubMed  Google Scholar 

  25. Wagner AD, Bjornsson J, Bartley GB, Goronzy JJ, Weyand CM. Interferon-γ-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol. 1996;148:1925–33.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM. Vessel-specific toll-like receptor profiles in human medium and large arteries. Circulation. 2008;118:1276–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Warrington KJ, Cooper LT. Rutherford’s vascular surgery: Elsevier; 2014. p. 1154–66.

    Google Scholar 

  28. Bossert M, Prati C, Balblanc J-C, Lohse A, Wendling D. Aortic involvement in giant cell arteritis: current data. Joint Bone Spine. 2011;78:246–51.

    Article  PubMed  Google Scholar 

  29. Narvaez J, Narvaez JA, Nolla JM, Sirvent E, Reina D, Valverde J. Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology. 2005;44:479–83.

    Article  CAS  PubMed  Google Scholar 

  30. Karunanithi S, Sharma P, Bal C, Kumar R. 18F-FDG PET/CT for diagnosis and treatment response evaluation in large vessel vasculitis. Eur J Nucl Med Mol Imaging. 2013;41:586–7.

    Article  PubMed  Google Scholar 

  31. Ponte C, Rodrigues AF, O’Neill L, Luqmani RA. Giant cell arteritis: Current treatment and management. In: World J Clin Cases (WJCC). 2015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468893/. Accessed 11 Dec 2016.

  32. Bongartz T, Matteson EL. Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol. 2006;18:10–7.

    Article  PubMed  Google Scholar 

  33. Hunder GG. Treatment of giant cell (temporal) arteritis. In: Treatment of giant cell (temporal) arteritis. 2016. http://www.uptodate.com/contents/treatment-of-giant-cell-temporal-arteritis. Accessed 15 Dec 2016.

  34. Martinez-Lado L, Calviño-Díaz C, Piñeiro A, Dierssen T, Vazquez-Rodriguez TR, Miranda-Filloy JA, Lopez-Diaz MJ, Blanco R, Llorca J, Gonzalez-Gay MA. Relapses and recurrences in giant cell arteritis. Medicine. 2011;90:186–93.

    Article  PubMed  Google Scholar 

  35. ACTEMRA [package insert]. South San Francisco, CA. Genentech, Inc. 2018.

    Google Scholar 

  36. Nuenninghoff DM, Hunder GG, Christianson TJH, Mcclelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522–31.

    Article  PubMed  Google Scholar 

  37. Schmidt WA, Moll A, Seifert A, Schicke B, Gromnica-Ihle E, Krause A. Prognosis of large-vessel giant cell arteritis. Rheumatology. 2008;47:1406–8.

    Article  CAS  PubMed  Google Scholar 

  38. Both M, Aries PM, Muller-Hulsbeck S, Jahnke T, Schafer PJ, Gross WL, Heller M, Reuter M. Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis. Ann Rheum Dis. 2006;65:1124–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Fassbender HG. Takayasu arteritis. Pathology and pathobiology of rheumatic diseases. 2nd ed. Berlin: Springer; 2002. p. 304.

    Book  Google Scholar 

  40. Johnston SL, Lock RJ, Gompels MM. J Clin Pathol; Takayasu: a review. Br Med Assoc. 2002;55:481–6.

    Google Scholar 

  41. Hunder GG. Clinical features and diagnosis of Takayasu arteritis. In: Clinical features and diagnosis of Takayasu arteritis. 2014. http://www.uptodate.com/contents/clinical-features-and-diagnosis-of-takayasu-arteritis. Accessed 10 Dec 2016.

  42. Norris M. Pathogenesis of Takayasu arteritis. J Nephrol. 2001;14(6):506–13.

    Google Scholar 

  43. Gravanis MB. Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors. Int J Cardiol. 2000;75:S21–33.

    Article  PubMed  Google Scholar 

  44. Arend WP, Michel BA, Bloch DA, Hunder GG, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990 Aug;33(8):1129–34.

    Article  CAS  PubMed  Google Scholar 

  45. Kerr GS, Hallahan CW, Giordano J, et al. Takayasu arteritis. Ann Int Me. 1994;120:919–29.

    Article  CAS  Google Scholar 

  46. Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease). Circulation. 1978;57:27–35.

    Article  CAS  PubMed  Google Scholar 

  47. Jain S, Sharma N, Singh S, et al. Takayasu arteritis in children and young Indians. Int J Cardiol. 2000;75:S153–7.

    Article  PubMed  Google Scholar 

  48. Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu’s disease). Circulation. 1989;80:429–37.

    Article  CAS  PubMed  Google Scholar 

  49. Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol. 2005;17:16–24.

    Article  CAS  PubMed  Google Scholar 

  50. Kissin EY, Merkel PA. Diagnostic imaging in Takayasu arteritis. Curr Opin Rheumatol. 2004;16:31–7.

    Article  PubMed  Google Scholar 

  51. Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004;50:2296–304.

    Article  CAS  PubMed  Google Scholar 

  52. Salvarani C, Magnani L, Catanoso M, Pipitone N, Versari A, Dardani L, Pulsatelli L, Meliconi R, Boiardi L. Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology. 2011;51:151–6.

    Article  CAS  PubMed  Google Scholar 

  53. Liang P, Tan-Ong M, HOfman GS. Takayasu’s arteritis: vascular interventions and outcomes. J Rheumatol. 2004;31:102–6.

    PubMed  Google Scholar 

  54. Myata T, Sato O, Koyama H, Shigematsu H, Tada Y. Long-term survival after surgical treatment of patients with Takayasu’s arteritis. Circulation. 2003;108:1474–80.

    Article  Google Scholar 

  55. Matsuura K, Ogino J, Kobayashi J, et al. Surgical treatment of aortic regurgitation due to Takayasu arteritis: long term morbidity and mortality. Circulation. 2005;112:3707–12.

    Article  PubMed  Google Scholar 

  56. Matsuura K, Ogino H, Matsuda H, et al. Surgical outcome of aortic arch repair for patients with Takayasu arteritis. Ann Thorac Surg. 2006;81:178–82.

    Article  PubMed  Google Scholar 

  57. Stone JH, Khosroshahi A, Deshpande V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 2012;64:3061–7. https://doi.org/10.1002/art.34593.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–51.

    Article  CAS  PubMed  Google Scholar 

  59. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.

    Article  CAS  PubMed  Google Scholar 

  60. Walker DI, Bloor K, Williams G, Gillie I. Inflammatory aneurysms of the abdominal aorta. Br J Surg. 1972;59:609–14.

    Article  CAS  PubMed  Google Scholar 

  61. Kasashima S, Zen Y, Kawashima A, et al. Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol. 2008;32:197–204.

    Article  PubMed  Google Scholar 

  62. Moutsopoulos HM, Fragoulis GE, Stone JH. Overview of IgG4-related disease. 2016. https://www.uptodate.com/contents/overview-of-igg4-related-disease. Accessed 16 Nov 2016.

  63. Uibu T, Oksa P, Auvinen A, et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet. 2004;363:1422–6.

    Article  CAS  PubMed  Google Scholar 

  64. Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:88–94.

    Article  CAS  PubMed  Google Scholar 

  65. Deshpande V, Zen Y, Chan JKC, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181–92.

    Article  PubMed  Google Scholar 

  66. Zen Y, Kasashima S, Inoue D. Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease. Semin Diagn Pathol. 2012;29:212–8.

    Article  PubMed  Google Scholar 

  67. Inoue D, Zen Y, Abo H, Gabata T, Demachi H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients. Radiology. 2011;261:625–33.

    Article  PubMed  Google Scholar 

  68. Kasashima S, Zen Y, Kawashima A, Endo M, Matsumoto Y, Kasashima F. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg. 2009;49:1264–71.

    Article  PubMed  Google Scholar 

  69. Stone JH, Khosroshahi A, Deshpande V, Stone JR. IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthritis Care Res. 2010;62:316–22.

    Article  Google Scholar 

  70. Rojo-Leyva F, Ratliff NB, Cosgrove DM, Hoffman GS. Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum. 2000;43:901.

    Article  CAS  PubMed  Google Scholar 

  71. Miller DV, Isotalo PA, Weyand CM, Edwards WD, Aubry M-C, Tazelaar HD. Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol. 2006:1150–8.

    Google Scholar 

  72. Khosroshahi A, Wallace ZS, Crowe JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67:1688–99.

    Article  CAS  PubMed  Google Scholar 

  73. Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:67–71.

    Article  CAS  PubMed  Google Scholar 

  74. Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, Deshpande V, Smyrk TC, Chari S, Stone JH. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171–7.

    Article  CAS  PubMed  Google Scholar 

  75. Kural-Seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H. The long-term mortality and morbidity of Behçet syndrome. Medicine. 2003;82:60–76.

    Article  PubMed  Google Scholar 

  76. Smith EL, Yazici Y. Clinical manifestations and diagnosis of Behçet’s syndrome. In: Clinical manifestations and diagnosis of Behçet’s syndrome. 2015. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-behcetssyndrome?source=search_result&search=bechet&selectedTitle=1~103. Accessed 22 Nov 2016.

  77. Yurdakul S, Hamuryudan V, Yazici H. Behçet syndrome. Curr Opin Rheumatol. 2004;16:38–42.

    Article  PubMed  Google Scholar 

  78. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999;341:1284–91.

    Article  CAS  PubMed  Google Scholar 

  79. Yazici, et al. Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet. 1990;335(8697):1078–80.

    Google Scholar 

  80. Iscan ZH, Vural KM, Bayazit M. Compelling nature of arterial manifestations in Behçet disease. J Vasc Surg. 2005;41:53–8.

    Article  PubMed  Google Scholar 

  81. Kuzu MA, Ozaslan C, Koksoy C, Gurler A, Tuzuner A. Vascular involvement in Behçet’s disease: 8-year audit. World J Surg. 1994;18:948–53.

    Article  CAS  PubMed  Google Scholar 

  82. Ozeren M, Mavioglu I, Dogan O, Yucel E. Reoperation results of arterial involvement in Behçet’s disease. Eur J Vasc Endovasc Surg. 2000;20:512–6.

    Article  CAS  PubMed  Google Scholar 

  83. Sarica-Kucukoglu R, Akdag-Kose A, Kayabal M, Yazganoglu KD, Disci R, Erzengin D, Azizlerli G. Vascular involvement in Behçet’s disease: a retrospective analysis of 2319 cases. Int J Dermatol. 2006;45:919–21.

    Article  PubMed  Google Scholar 

  84. Matsumoto T, Uekusa T, Fukuda Y. Vasculo-Behçet’s disease: a pathologic study of eight cases. Hum Pathol. 1991;22:45–51.

    Article  CAS  PubMed  Google Scholar 

  85. Park J, Han M, Bettmann M. Arterial manifestations of Behçet disease. Am J Roentgenol. 1984;143:821–5.

    Article  CAS  Google Scholar 

  86. Direskeneli H. Behçet’s disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis. 2001;60:996–1002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  87. Verity DH. Behçet’s disease: from Hippocrates to the third millennium. Br J Ophthalmol. 2003;87:1175–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet’s syndrome. J Am Coll Cardiol. 2001;37:517–20.

    Article  CAS  PubMed  Google Scholar 

  89. Oflaz H, Mercanoglu F, Karaman O, Kamali S, Erer B, Genchellac H, Pamukcu B, Umman S, Inanc M, Gul A. Impaired endothelium-dependent flow-mediated dilation in Behçet’s disease: more prominent endothelial dysfunction in patients with vascular involvement. Int J Clin Pract. 2005;59:777–81.

    Article  CAS  PubMed  Google Scholar 

  90. Hatemi G, Silman A, Bang D, et al. EULAR recommendations for the management of Behçet disease. Ann Rheum Dis. 2008;67:1656–62.

    Article  CAS  PubMed  Google Scholar 

  91. Barnes CG. Treatment of Behcet’s syndrome. Rheumatology. 2006;45:245–7.

    Article  CAS  PubMed  Google Scholar 

  92. Lê Thi Huong D, Wechsler B, Papo T, et al. Arterial lesions in Behçet’s disease. A study in 25 patients. J Rheumatol. 1995;22:2103.

    PubMed  Google Scholar 

  93. Smith EL, Yazici Y. Treatment of Behçet’s syndrome. In: Treatment of Behçet’s syndrome. 2015. http://www.uptodate.com/contents/treatment-of-behcets-syndrome. Accessed 13 Nov 2016.

  94. Tunaci A, Berkmen YM, Gökmen E. Thoracic involvement in Behçet’s disease: pathologic, clinical, and imaging features. Am J Roentgenol. 1995;164:51–6.

    Article  CAS  Google Scholar 

  95. Khan MA. Ankylosing spondylitis: clinical features. In: Klippel JH, Dieppe PA, editors. Rheumatology. 2nd ed. London: Mosby; 1998. p. 6.16.1–6.16.10.

    Google Scholar 

  96. Yu DT, van Tubergen A. Clinical manifestations of ankylosing spondylitis in adults. In: Clinical manifestations of ankylosing spondylitis in adults. 2015. http://www.uptodate.com/contents/clinical-manifestations-of-ankylosing-spondylitis-in-adults. Accessed 30 Nov 2016.

  97. Bulkley BH, Roberts WC. Ankylosing spondylitis and aortic regurgitation: description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973;48:1014–27.

    Article  CAS  PubMed  Google Scholar 

  98. Bergfeldt L. HLA-B27-associated cardiac disease. Ann Intern Med. 1997;127:621.

    Article  CAS  PubMed  Google Scholar 

  99. Qaiyumi S. Seronegative spondyloarthropathies in lone aortic insufficiency. Arch Intern Med. 1985;145:822–4.

    Article  CAS  PubMed  Google Scholar 

  100. Moyssakis I, Gialafos E, Vassiliou VA, Boki K, Votteas V, Sfikakis PP, Tzelepis GE. Myocardial performance and aortic elasticity are impaired in patients with ankylosing spondylitis. Scand J Rheumatol. 2009;38:216–21.

    Article  CAS  PubMed  Google Scholar 

  101. Roldan CA, Chavez J, Wiest PW, Qualls CR, Crawford MH. Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol. 1998;32:1397–404.

    Article  CAS  PubMed  Google Scholar 

  102. Palazzi C, Salvarani C, D'Angelo S, Olivieri I. Aortitis and periaortitis in ankylosing spondylitis. Joint Bone Spine. 2011;78:451–5.

    Article  PubMed  Google Scholar 

  103. Kawasuji M, Hetzer R, Oelert H, Stauch G, Borst H. Aortic valve replacement and ascending aorta replacement in ankylosing spondylitis: report of three surgical cases and review of the literature. Thorac Cardiovasc Surg. 1982;30:310–4.

    Article  CAS  PubMed  Google Scholar 

  104. Seo JW, Park IA, Yoon DH, Lee SK, Ahn H, Park YB, Song YW. Thoracic aortic aneurysm associated with aortitis–case reports and histological review. J Korean Med Sci. 1991;6:75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Stamp L, Lambie N, O’Donnell J. HLA-B27 associated spondyloarthropathy and severe ascending aortitis. J Rheumatol. 2000;27:2038–40.

    CAS  PubMed  Google Scholar 

  106. Takagi H, Mori Y, Umeda Y, Fukumoto Y, Kato Y, Shimokawa K, Hirose H. Abdominal aortic aneurysm with arteritis in ankylosing spondylitis. J Vasc Surg. 2003;38:613–6.

    Article  PubMed  Google Scholar 

  107. Deodhar A, Reveille JD, Bosch FVD, et al. The concept of axial spondyloarthritis: joint statement of the spondyloarthritis research and treatment network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration’s comments and concerns. Arthritis Rheumatol. 2014;66:2649–56.

    Article  CAS  PubMed  Google Scholar 

  108. Kiltz U, Heijde DVD, Boonen A, et al. Development of a Health Index in Patients with Ankylosing Spondylitis (ASAS HI), a final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis. 2013; https://doi.org/10.1136/annrheumdis-2013-eular.419.

    Google Scholar 

  109. Yu DT. Assessment and treatment of ankylosing spondylitis in adults. In: Assessment and treatment of ankylosing spondylitis in adults. 2016. http://www.uptodate.com/contents/assessment-and-treatment-of-ankylosing-spondylitis-in-adults. Accessed 10 Oct 2016.

  110. Lautermann D, Braun J. Ankylosing spondylitis – cardiac manifestations. In: Clinical and Experimental Rheumatology. 2002. http://www.clinexprheumatol.org/abstract.asp?a=1454. Accessed 10 Oct 2016.

  111. Berg RVD, Baraliakos X, Braun J, Heijde DVD. First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis. Rheumatology. 2012;51:1388–96.

    Article  CAS  PubMed  Google Scholar 

  112. Slobodin G, Naschitz JE, Zuckerman E, Zisman D, Rozenbaum M, Boulman N, Rosner I. Aortic involvement in rheumatic diseases. Clin Exp Rheumatol. 2006;24:S41–7.

    CAS  PubMed  Google Scholar 

  113. Gravallese EM, Corson JM, Coblyn JS, Pincus GS, Weinblatt ME. Rheumatoid aortitis: a rarely recognized but clinically significant entity. Medicine. 1989;68:95–106.

    Article  CAS  PubMed  Google Scholar 

  114. Guedes C, Bianchi-Fior P, Cormier B, Barthelemy B, Rat AC, Boissier MC. Cardiac manifestations of rheumatoid arthritis: a case-control transesophageal echocardiography study in 30 patients. Arthritis Rheum. 2001;45:129–35.

    Article  CAS  PubMed  Google Scholar 

  115. Khan AS, Spiera H. Association of aortic aneurysm in patients with systemic lupus erythematosus: a series of case reports and a review of literature. J La State Med Soc. 1996;148:55–9.

    Google Scholar 

  116. Choi KH, Rim S-J, Lee SK, Jang BC, Cho SH. Discussing aortic aneurysm with aortic valve insufficiency in systemic lupus erythematosus. Neprol Dial Transplant. 1999;14:969–73.

    Article  CAS  Google Scholar 

  117. Hussain KM, Chandna H, Santhanam V, Seghal S, Jain A, Denes O. Aortic dissection in a young corticosteroid treated patient with systemic lupus erythematous – a case report. Angiology. 1998;49:649–52.

    Article  CAS  PubMed  Google Scholar 

  118. Aoyagi S, Akashi H, Otsuka H, Sakashita H, Okazaki T, Tayama K. Acute type A aortic dissection in a patient with systemic lupus erythematosus. Jpn Heart J. 2002, 43:567–71.

    Article  PubMed  Google Scholar 

  119. St Clair EW, McCallum RM. Cogan’s syndrome. Curr Opin Rheumatol. 1999;11:47–58.

    Article  CAS  PubMed  Google Scholar 

  120. Vollersten RS, McDonald TJ, Younge BR, Banks PM, Stanson AM, Ilstrup DM. Cogan’s syndrome: 18 cases and a review of the literature. Mayo Clin Proc. 1986;61:344–61.

    Article  Google Scholar 

  121. Cochrane AD, Tatoulis J. Cogan’s syndrome with aortitis, aortic regurgitation, and aortic arch vessel stenosis. Ann Thorac Surg. 1991;52:1166–7.

    Article  CAS  PubMed  Google Scholar 

  122. Haynes BF, Kaiser-Kupfer MI, Mson P, Fauci AS. Cogan syndrome: studies in in thirteen patients, long term follow-up, and a review of the literature. Medicine. 1980;59:426–40.

    Article  CAS  PubMed  Google Scholar 

  123. Livingston JZ, Casale AS, Hutchins GM, Shapiro EP. Coronary involvement in Cogan’s syndrome. Am Heart J. 1992;123:528–30.

    Article  CAS  PubMed  Google Scholar 

  124. Judge DP, Dietz HC. Marfan’s syndrome. Lancet. 2005;366:1965–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  125. Milewicz DM, Dietz HC, Miller DC. Treatment of aortic disease in patients with Marfan syndrome. Circulation. 2005;111:e150–7.

    Article  PubMed  Google Scholar 

  126. Graham T. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Yearbook of Cardiology. 2011;2011:142–3.

    Article  Google Scholar 

  127. Lee B, Godfrey M, Vitale E, et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature. 1991;352:337–9.

    Article  Google Scholar 

  128. Mizuguchi T, Collod-Beroud G, Akiyama T, et al. Heterozygous TGFBR2 mutations in marfan’s syndrome. Nat Genet. 2004;36:855–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Loeys BL, Chen J, Neptune ER, et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005 Mar;37(3):275–81.

    Article  CAS  PubMed  Google Scholar 

  130. Roman MJ, Rosen SE, Kramer-Fox R, Devereux RB. Prognostic significance of the pattern of aortic root dilation in the Marfan syndrome. J Am Coll Cardiol. 1993;22:1470–6.

    Article  CAS  PubMed  Google Scholar 

  131. Cherry FJ, Dake MD. Comprehensive vascular and endovascular surgery: Elsevier; 2009. p. 517–31.

    Chapter  Google Scholar 

  132. Lacro RV, Dietz HC, Sleeper LA, Yetman AT, Bradley TJ, Colan SD, Pearson GD, Selamet Tierney ES, Levine JC, Atz AM, Benson DW, Braverman AC, Chen S, De Backer J, Gelb BD, Grossfeld PD, Klein GL, Lai WW, Liou A, Loeys BL, Markham LW, Olson AK, Paridon SM, Pemberton VL, Pierpont ME, Pyeritz RE, Radojewski E, Roman MJ, Sharkey AM, Stylianou MP, Burns Wechsler S, Young LT, Mahony L. Atenolol versus losartan in children and young adults with Marfan’s syndrome. N Engl J Med. 2014;371:2061–71.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  133. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC. Angiotensin II blockade and aortic-rot dilation in Marfan’s syndrome. N Engl J Med. 2008;358:2787–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Gott VL, Greene PS, Alejo DE, et al. Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med. 1999;340:1307–13.

    Article  CAS  PubMed  Google Scholar 

  135. David TE, Feindel CM, Webb GD, Coleman JM, Armstrong S, Maganti M. Long term results of aortic valve-sparing operations for aortic root aneurysm. J Thorac Cardiovasc Surg. 2006;132:347–54.

    Article  PubMed  Google Scholar 

  136. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet. 1998;77:31–7.

    Article  CAS  PubMed  Google Scholar 

  137. Silver FH, Horvath I, Foran DJ. Viscoelasticity of the Vessel Wall: the role of collagen and elastic fibers. Crit Rev Biomed Eng. 2001;29:279–302.

    Article  CAS  PubMed  Google Scholar 

  138. Pepin M, Schwarze U, Superti-Fugera A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med. 2000;342:673–80.

    Article  CAS  PubMed  Google Scholar 

  139. Germain DP. Clinical and genetic features of vascular Ehlers-Danlos syndrome. Ann Vasc Surg. 2002;16:391–7.

    Article  PubMed  Google Scholar 

  140. Beridze N, Frishman WH. Vascular Ehlers-Danlos syndrome. Cardiol Rev. 2012;20:004–7.

    Article  Google Scholar 

  141. Germain DP, Herrera-Guzman Y. Vascular Ehlers-Danlos syndrome. Ann Genet. 2004;47:1–9.

    Article  PubMed  Google Scholar 

  142. Berillis P. The role of collagen in the Aorta’s structure. Open Circulation Vascular J. 2013;6:1–8.

    Article  CAS  Google Scholar 

  143. Menashi S, Campa JS, Greenhalgh RM, Powell JT. Collagen in abdominal aortic aneurysm: typing, content, and degradation. J Vasc Surg. 1987;6:578–82.

    Article  CAS  PubMed  Google Scholar 

  144. Oderich GS, Panneton JM, ,Bower TC et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV, a 30 year experience. J Vasc Surg 2005;42:98–106.

    Article  PubMed  Google Scholar 

  145. Wenstrup RJ, Meyer RA, Lyle JS, et al. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. Genet Med. 2002;4:112–7.

    Article  PubMed  Google Scholar 

  146. Ong K-T, Perdu J, Debacker J. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomized, open blinded-endpoints trial. J Vasc Surg. 2011;53:879.

    Article  Google Scholar 

  147. Chu LC, Johnson PT, Dietz HC, Fishman EK. CT angiographic evaluation of genetic vascular disease: role in detection, staging, and management of complex vascular pathologic conditions. Am J Roentgenol. 2014;202:1120–9.

    Article  Google Scholar 

  148. Nourissat G, et al. A case of dissecting aneurysm of the superior mesenteric artery due to Ehlers Danlos Type IV. EJVES Extra. 2010;19(6):e58–63.

    Article  Google Scholar 

  149. Freeman RK, Swegle J, Sise MJ. The surgical complications of Ehlers-Danlos syndrome. Am Surg. 1996;62:869–73.

    CAS  PubMed  Google Scholar 

  150. Brooke BS, Arnaoutakis G, Mcdonnell NB, Black JH. Contemporary management of vascular complications associated with Ehlers-Danlos syndrome. J Vasc Surg. 2010;51:131–9.

    Article  PubMed  Google Scholar 

  151. Prockop DJ, Kivirikko KI. Heritable diseases of collagen. N Engl J Med. 1984;311(6):376.

    Article  CAS  PubMed  Google Scholar 

  152. Marini JC. Osteogenesis imperfecta: comprehensive management. Adv Pediatr Infect Dis. 1988;35:391.

    CAS  Google Scholar 

  153. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979;16:101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  154. Rauch F, Glorieux FH. Osteogenesis Imperfecta. Lancet. 2004;363:1377–85.

    Article  CAS  PubMed  Google Scholar 

  155. Glorieux FH, Ward LM, Rauch F, et al. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect. J Bone Miner Res. 2002;17:30.

    Article  PubMed  Google Scholar 

  156. Lodish H, Berk A, Zipursky SL, et al. Molecular cell biology. 4th ed. New York: W. H. Freeman; 2000.

    Google Scholar 

  157. Hurtop J, Tspourus P, Hanley JA, Maron B, Shapiro JR. Cardiovascular Involvement in Osteogenisis Imperfecta. Circulation. 1986;73:54–61.

    Article  CAS  PubMed  Google Scholar 

  158. Braverman AC, Guven H, Beardslee MA, Makan M, Kates AM, Moon MR. The bicuspid aortic valve. Curr Probl Cadiol. 2005;30:470–522.

    Article  Google Scholar 

  159. Verma S, Siu S. Aortic dilatation in patients with bicuspid aortic valve. N Engl J Med. 2014;370(20):1920–9.

    Article  CAS  PubMed  Google Scholar 

  160. Cecconi M, Nistri S, Quarti A, et al. Aortic dilatation in patients with bicuspid aortic valve. J Cardiovasc Med (Hagerstown). 2006;7:11–20.

    Article  Google Scholar 

  161. Biner S, Rafique A, Ray I, Cuk O, Siegel RJ, Tolstrup K. Aortopathy is prevalent in relatives of bicuspid aortic valve patients. J Am Coll Cardiol. 2009;53(24):2288–95.

    Article  PubMed  PubMed Central  Google Scholar 

  162. Jacobs ML, Austen WG. Acquired aortic valve disease. In: Sabiston DC, Spencer FC, editors. Surgery of the chest. Philadelphia: W.B. Saunders Co.; 1990. p. 1566–96.

    Google Scholar 

  163. Chan KL, Stinson WA, Veinot JP. Reliability of transthoracic echocardiography in the assessment of aortic valve morphology: pathologic correlation in 178 patients. Can J Cardiol. 1999;15:48–52.

    CAS  PubMed  Google Scholar 

  164. Espinal M, Fuisz AR, Nanda NC, Aaluri SR, Mukhtar O, Sekar P. Sensitivity and specificity of transesophageal echocardiography for determination of aortic valve morphology. Am Heart J. 2000;139:1071–6.

    Article  CAS  PubMed  Google Scholar 

  165. Michelena HI, et al. Bicuspid aortic valve aortopathy in adults: incidence, etiology, and clinical significance. Int J Cardiol. 2015;201:400–7.

    Article  PubMed  Google Scholar 

  166. Beppu S, Suzuki S, Matsuda H, et al. Rapidity of progression of aortic stenosis in patients with congenital bicuspid aortic valve. Am J Cardiol. 1993;71:322–7.

    Article  CAS  PubMed  Google Scholar 

  167. Mautner GC, Mautner SL, Cannon RD, et al. Clinical factors useful in predicting aortic valve structure in patients >40 years of age with isolated valvular aortic stenosis. Am J Cardiol. 1993;72:194–8.

    Article  CAS  PubMed  Google Scholar 

  168. Roberts WC. The congenitally bicuspid aortic valve. Am J Cardiol. 1970;26:72–83.

    Article  CAS  PubMed  Google Scholar 

  169. Grant RT, Wood JE, Jones TD. Heart valve irregularities in relation to sub-acute bacterial endocarditis. Heart. 1928;14:247–55.

    Google Scholar 

  170. Roberts WC, Morrow AG, McIntosh CL, et al. Congenitally bicuspid aortic valve causing severe pure aortic regurgitation without superimposed infective endocarditis. Am J Cardiol. 1981;47:206–9.

    Article  CAS  PubMed  Google Scholar 

  171. Guiney TE, Davies MJ, Parker DJ, et al. The etiology and course of isolated severe aortic regurgitation. Ann Intern Med. 1987;58:358–68.

    CAS  Google Scholar 

  172. Lamas CC, Eykyn SJ. Bicuspid aortic valve–a silent danger: analysis of 50 cases of infective endocarditis. Clin Infect Dis. 2000;30:336–41.

    Article  CAS  PubMed  Google Scholar 

  173. Janatuinen MJ, Vanttinen EA, Nikoskelainen J, Inberg MV. Surgical treatment of active native endocarditis. Scand J Thorac Cardiovasc Surg. 1990;24:181–5.

    Article  CAS  PubMed  Google Scholar 

  174. Varstela E, Verkkala K, Pohjola-Sintonen S, Valtonen V, Maamies T. Surgical treatment of infective aortic valve endocarditis. Scand J Thorac Cardiovasc Surg. 1991;25:167–74.

    Article  CAS  PubMed  Google Scholar 

  175. Michel PL, Aubert I, Boustani F, Acar J. Chirurgie de l’insuffisance aortique bacterienne. Indications et resultats. Ann Med Interne (Paris). 1987;138:610–4.

    CAS  Google Scholar 

  176. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121:e266–369.

    PubMed  Google Scholar 

  177. Siu SC, Silversides CK. Bicuspid aortic valve disease. J Am Coll Cardiol. 2010;55:2789–800.

    Article  PubMed  Google Scholar 

  178. Bonderman D, Gharehbaghi-Schnell E, Wollenck G, Maurer G, Buamgartner H, Lang IM. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation. 1999;99:2138–43.

    Article  CAS  PubMed  Google Scholar 

  179. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to develop guidelines for the Management of Adults with Congenital Heart Disease). Circulation 2008;118:e714–e833.

    Google Scholar 

  180. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, Thomas JD. AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;2014:129.

    Google Scholar 

  181. Tzemos N, Therrien J, Yip J, et al. Outcomes in adults with bicuspid aortic valves. St Loius, Mo: JAMA. 2008;300:1317–25.

    Article  CAS  PubMed  Google Scholar 

  182. Russo CF, Mazzetti S, Garatti A, et al. Aortic complications after bicuspid aortic valve replacement: long term results. St Loius, Mo: Ann Thorac Surg. 2002;74:S1773–6. discussion S1792–9

    Google Scholar 

Suggested Reading

  • Alexiou C, Langley SM, Charlesworth P, Haw MP, Haverich A. Aortic root replacement in patients with Marfan’s syndrome: the Southhampton experience. Ann Thorac Surg. 2001;72:1502–7.

    Article  CAS  PubMed  Google Scholar 

  • Beenakker JWM, Ashcroft BA, Lindeman JHN, Oosterkamp TH. Mechanical properties of the extracellular matrix of the aorta studied by enzymatic treatments. Biophys J. 2012;102:1731–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bergqvist D. Ehlers-Danlos type IV syndrome. A review from a vascular surgical point of view. Eur J Surg. 1996;162:163–70.

    CAS  PubMed  Google Scholar 

  • Brandenburg RO Jr, Tajik AJ, Edwards WD, et al. Accuracy of 2-dimensional echocardiographic diagnosis of congenitally bicuspid valve: echocardiographic-anatomic correlation in 115 patients. Am J Cardiol 1973;83: 1469–1473.

    Google Scholar 

  • Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM. Epidemiology and clinical characteristics of Behçet’s disease in the US: a population-based study. Arthritis Rheum. 2009;61:600–4.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hall S, Barr W, Lie JT, et al. Takayasu arteritis. A study of 32 North American patients. Medicine. 1985;64:89–99.

    Article  CAS  PubMed  Google Scholar 

  • Kamisawa T, Anjiki H, Egawa N, Kubota N. Allergic manifestations in autoimmune pancreatitis. Eur J Gastroenterol Hepatol. 2009;21:1136–9.

    Article  PubMed  Google Scholar 

  • Karck M, Kallenbach K, Hagl C, Rhein C, Leyh R, Haverich A. Aortic root surgery in Marfan syndrome: comparison of aortic valve-sparing reimplantation versus composite grafting. J Thorac Cadiovasc Surg. 2004;127:391–8.

    Article  Google Scholar 

  • Maltz SB, Fantus RJ, Mellett MM, Kirby JP. Surgical complications of Ehlers-Danlos syndrome type IV: case report and review of literature. J Trauma. 2001;51:387–90.

    Article  CAS  PubMed  Google Scholar 

  • Osler W. The bicuspid condition of the aortic valves. Trans Assoc Am Phys. 1886;1:185–92.

    Google Scholar 

  • Vouyouka AG, Pfeiffer BJ, Liem TK, Taylor TA, Mudaliar J, Phillips CL, Mo C. The role of type I collagen in aortic wall strength with a homotrimeric [α1(I)]3 collagen mouse model. 20. J Vasc Surg. 2001;33:1263–70.

    Article  CAS  PubMed  Google Scholar 

  • Weyand CM, Younge BR, Goronzy JJ. IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol. 2011;23:43–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology, Loyola University Medical Center, Maywood, IL, USA

    Brittany S. Panico

  2. Cardiology, Loyola University Medical Center, Maywood, IL, USA

    Ambrose F. Panico

  3. Interventional Cardiology, Vascular and Endovascular Medicine, Loyola University Medical Center, Maywood, IL, USA

    Robert S. Dieter

Authors
  1. Brittany S. Panico
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ambrose F. Panico
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert S. Dieter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Interventional Cardiology, Vascular and Endovascular Medicine, Loyola University Medical Center, Maywood, IL, USA

    Robert S. Dieter

  2. Cardiovascular and Thoracic Surgery, Northwestern University at Cadence Health Emeritus, Winfield, IL, USA

    Raymond A. Dieter Jr.

  3. University of Tennessee Medical Center, Cardiovascular and Thoracic Surgery, Knoxville, TN, USA

    Raymond A. Dieter III

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Panico, B.S., Panico, A.F., Dieter, R.S. (2019). Inflammatory and Connective Tissue Disorders of the Aorta. In: Dieter, R., Dieter Jr., R., Dieter III, R. (eds) Diseases of the Aorta . Springer, Cham. https://doi.org/10.1007/978-3-030-11322-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11322-3_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-11321-6

  • Online ISBN: 978-3-030-11322-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation